Yew Bio-Pharm Group (OTCMKTS:YEWB) and BRASILAGRO COMP/S (NYSE:LND) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, earnings, risk and institutional ownership.
This is a summary of recent recommendations and price targets for Yew Bio-Pharm Group and BRASILAGRO COMP/S, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Yew Bio-Pharm Group||0||0||0||0||N/A|
This table compares Yew Bio-Pharm Group and BRASILAGRO COMP/S’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Yew Bio-Pharm Group||-17.24%||-13.98%||-11.94%|
Institutional & Insider Ownership
0.5% of BRASILAGRO COMP/S shares are held by institutional investors. 63.7% of Yew Bio-Pharm Group shares are held by company insiders. Comparatively, 0.7% of BRASILAGRO COMP/S shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Yew Bio-Pharm Group and BRASILAGRO COMP/S’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Yew Bio-Pharm Group||$40.54 million||0.21||$3.21 million||N/A||N/A|
|BRASILAGRO COMP/S||$119.63 million||1.85||$38.10 million||N/A||N/A|
BRASILAGRO COMP/S has higher revenue and earnings than Yew Bio-Pharm Group.
Risk and Volatility
Yew Bio-Pharm Group has a beta of 0.84, meaning that its stock price is 16% less volatile than the S&P 500. Comparatively, BRASILAGRO COMP/S has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.
BRASILAGRO COMP/S pays an annual dividend of $0.18 per share and has a dividend yield of 4.6%. Yew Bio-Pharm Group does not pay a dividend. BRASILAGRO COMP/S has raised its dividend for 3 consecutive years.
BRASILAGRO COMP/S beats Yew Bio-Pharm Group on 10 of the 11 factors compared between the two stocks.
Yew Bio-Pharm Group Company Profile
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's Republic of China. It operates through four segments: Traditional Chinese Medicine (TCM) Raw Materials, Yew Trees, Handicrafts, and Others. The TCM Raw Materials segment engages in the production and sale of raw materials that are used in the manufacture of TCM. It offers yew raw materials, including branches and leaves of yew trees. The Yew Tree segment is involved in growing and selling yew seedlings and mature trees. It cultivates and sells yew seedlings and trees to state-owned enterprises and private businesses for reforestation in the provinces of Heilongjiang and Jilin; and sells potted yew trees to retail customers. The Handicrafts segment manufactures and sells furniture and handicrafts made of yew timber. The Others segment sells yew candles, pine needle extracts, complex taxus cuspidate extract, composite northeast yew extract, and yew essential oil soap. The company also sells wood ear mushroom. Yew Bio-Pharm Group, Inc. was incorporated in 2007 and is based in El Monte, California.
BRASILAGRO COMP/S Company Profile
BrasilAgro – Companhia Brasileira de Propriedades Agrícolas engages in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities in Brazil. The company operates through five segments: Real Estate, Grains, Sugarcane, Cattle Raising, and Other. It is involved in the cultivation of soybean, corn, sorghum, and cotton, as well as sugarcane; and production and sale of beef calves after weaning. The company has 10 farms in 6 Brazilian states and 1 joint-venture farm in Paraguay with a total area of 198,158 hectares of own lands and 26,763 hectares of leased lands. It also imports and exports agricultural products and inputs; purchases, sells, and/or rents properties, land, buildings, and real estate in rural and/or urban areas; provides real estate brokerage services; and manages third-party assets. The company was incorporated in 2005 and is headquartered in Sao Paulo, Brazil.
Receive News & Ratings for Yew Bio-Pharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yew Bio-Pharm Group and related companies with MarketBeat.com's FREE daily email newsletter.